1. |
尹周一, 王梦圆, 游伟程, 等. 2022美国癌症统计报告解读及中美癌症流行情况对比. 肿瘤综合治疗电子杂志, 2022, 8(2): 54-63.
|
2. |
Lyman GH. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer, 2011, 117(7): 1334-1349.
|
3. |
Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res, 2010, 125(6): 490-493.
|
4. |
于欢, 张岚, 孔亚男, 等. 肺癌术后患者使用间歇充气加压装置预防静脉血栓栓塞症依从性的质性研究. 锦州医科大学学报, 2023, 44(1): 70-74.
|
5. |
崔超毅, 张荣, 宋菊民, 等. 腹部外科病人术后症状性静脉血栓栓塞症中心临床流行病学研究. 中国实用外科杂志, 2020, 40(5): 547-550, 556.
|
6. |
王敬瀚. ROC曲线在临床医学诊断实验中的应用. 中华高血压杂志, 2008, 16(2): 175-177.
|
7. |
Gerotziafas GT, Taher A, Abdel-Razeq H, et al. A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS-cancer-associated thrombosis study. Oncologist, 2017, 22(10): 1222-1231.
|
8. |
李积凤, 杨媛华. 《肺血栓栓塞症诊治与预防指南》—关于静脉血栓栓塞症预防的推荐意见. 中国医刊, 2018, 53(10): 1078-1082.
|
9. |
Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol, 2020, 38(5): 496-520.
|
10. |
Cronin M, Dengler N, Krauss ES, et al. Completion of the updated Caprini risk assessment model (2013 Version). Clin Appl Thromb Hemost, 2019, 25: 1076029619838052.
|
11. |
Gerotziafas GT, Mahé I, Lefkou E, et al. Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer. Thromb Res, 2020, 191 Suppl 1: S50-S57.
|
12. |
Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood, 2008, 111(10): 4902-4907.
|
13. |
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the padua prediction score. J Thromb Haemost, 2010, 8(11): 2450-2457.
|
14. |
Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet, 1997, 350(9094): 1795-1798.
|
15. |
杨淼, 谢晶, 马亮英, 等. 3种血栓风险评估表对老年下肢骨折病人术后并发深静脉血栓的预测价值. 实用老年医学, 2021, 35(9): 914-917.
|
16. |
Dozio E, Vettoretti S, Caldiroli L, et al. Advanced glycation end products (AGE) and soluble forms of AGE receptor: emerging role as mortality risk factors in CKD. Biomedicines, 2020, 8(12): 638.
|
17. |
Autar R. Nursing assessment of clients at risk of deep vein thrombosis (DVT): the Autar DVT scale. J Adv Nurs, 1996, 23(4): 763-770.
|
18. |
陈晓洁, 汪永坚, 俞菁菁, 等. Autar量表在预防乳腺癌术后并发下肢深静脉血栓形成应用的效果观察. 护理研究, 2016, 30(19): 2414-2415.
|
19. |
詹爱丁, 蒋国洪. 改良Autar量表在妇科肿瘤术后深静脉血栓预防中的应用. 全科护理, 2017, 15(25): 3142-3143.
|